Literature DB >> 10847583

The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.

C M Boney1, P A Gruppuso, R A Faris, A R Frackelton.   

Abstract

Insulin-like growth factor-I (IGF-I) stimulates mitogenesis in proliferating preadipocytes, but when cells reach confluence and become growth arrested, IGF-I stimulates differentiation into adipocytes. IGF-I induces signaling pathways that involve IGF-I receptor-mediated tyrosine phosphorylation of Shc and insulin receptor substrate 1 (IRS-1). Either of these adaptor proteins can lead to activation of the three-kinase cascade ending in activation of the extracellular signal-regulated kinase 1 and -2 (ERK-1 and -2) mitogen-activated protein kinases (MAPKs). Several lines of evidence suggest that activation of MAPK inhibits 3T3-L1 preadipocyte differentiation. We have shown that IGF-I stimulation of MAPK activity is lost as 3T3-L1 preadipocytes begin to differentiate. This change in MAPK signaling coincides with loss of IGF-I-mediated Shc, but not IRS-1, tyrosine phosphorylation. We hypothesized that down-regulation of MAPK via loss of proximal signaling through Shc is an early component in the IGF-I switch from mitogenesis to differentiation in 3T3-L1 preadipocytes. Treatment of subconfluent cells with the MEK inhibitor PD098059 inhibited both IGF-I-activation of MAPK as well as 3H-thymidine incorporation. PD098059, in the presence of differentiation-inducing media, accelerated differentiation in subconfluent cells as measured by expression of adipocyte protein-2 (aP-2), peroxisome proliferator-activated receptor gamma (PPARgamma) and lipoprotein lipase (LPL). Transient transfection of subconfluent cells with Shc-Y317F, a dominant-negative mutant, attenuated IGF-I-mediated MAPK activation, inhibited DNA synthesis, and accelerated expression of differentiation markers aP-2, PPARgamma, and LPL. We conclude that signaling through Shc to MAPK plays a critical role in mediating IGF-I-stimulated 3T3-L1 mitogenesis. Our results suggest that loss of the ability of IGF-I to activate Shc signaling to MAPK may be an early component of adipogenesis in 3T3-L1 cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10847583     DOI: 10.1210/mend.14.6.0487

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  23 in total

1.  Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.

Authors:  Gang Xi; Xinchun Shen; Yashwanth Radhakrishnan; Laura Maile; David Clemmons
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 2.  The IGF-I regulatory system and its impact on skeletal and energy homeostasis.

Authors:  Masanobu Kawai; Clifford J Rosen
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

3.  Growth factor signals in neural cells: coherent patterns of interaction control multiple levels of molecular and phenotypic responses.

Authors:  Bronwen Martin; Randall Brenneman; Erin Golden; Tom Walent; Kevin G Becker; Vinayakumar V Prabhu; William Wood; Bruce Ladenheim; Jean-Lud Cadet; Stuart Maudsley
Journal:  J Biol Chem       Date:  2008-11-26       Impact factor: 5.157

Review 4.  Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells.

Authors:  Richard J Santen; Robert X Song; Shigeru Masamura; Wei Yue; Ping Fan; Tetsuya Sogon; Shin-ichi Hayashi; Kei Nakachi; Hidtek Eguchi
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

5.  Recruitment of Pyk2 to SHPS-1 signaling complex is required for IGF-I-dependent mitogenic signaling in vascular smooth muscle cells.

Authors:  Xinchun Shen; Gang Xi; Yashwanth Radhakrishnan; David R Clemmons
Journal:  Cell Mol Life Sci       Date:  2010-06-03       Impact factor: 9.261

6.  Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation.

Authors:  Kyung-Ah Kim; Jung-Hyun Kim; Yuhui Wang; Hei Sook Sul
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

7.  The Role of Cellular Proliferation in Adipogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stem Cells.

Authors:  Maribel P Marquez; Frances Alencastro; Alma Madrigal; Jossue Loya Jimenez; Giselle Blanco; Alex Gureghian; Laura Keagy; Cecilia Lee; Robert Liu; Lun Tan; Kristen Deignan; Brian Armstrong; Yuanxiang Zhao
Journal:  Stem Cells Dev       Date:  2017-10-04       Impact factor: 3.272

8.  Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.

Authors:  Yan Ling; Laura A Maile; Jaroslava Lieskovska; Jane Badley-Clarke; David R Clemmons
Journal:  Mol Biol Cell       Date:  2005-05-11       Impact factor: 4.138

9.  Differential signaling by adaptor molecules LRP1 and ShcA regulates adipogenesis by the insulin-like growth factor-1 receptor.

Authors:  Estelle Woldt; Rachel L Matz; Jérome Terrand; Mohamed Mlih; Céline Gracia; Sophie Foppolo; Sophie Martin; Véronique Bruban; Julie Ji; Emilie Velot; Joachim Herz; Philippe Boucher
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

10.  p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.

Authors:  Gang Xi; Xinchun Shen; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.